ID   YAP1_RAT                Reviewed;         469 AA.
AC   Q2EJA0; Q3LRU4; Q3LRU5; Q3LRU6;
DT   20-APR-2010, integrated into UniProtKB/Swiss-Prot.
DT   21-MAR-2006, sequence version 1.
DT   02-OCT-2024, entry version 125.
DE   RecName: Full=Transcriptional coactivator YAP1;
DE            Short=Yes-associated protein 1;
DE   AltName: Full=Protein yorkie homolog;
DE   AltName: Full=Yes-associated protein YAP65 homolog;
GN   Name=Yap1; Synonyms=Yap, Yap65;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2; 3 AND 4), FUNCTION, INDUCTION,
RP   AND TISSUE SPECIFICITY.
RC   STRAIN=Wistar;
RX   PubMed=16461361; DOI=10.1083/jcb.200509132;
RA   Hoshino M., Qi M.-L., Yoshimura N., Tagawa K., Wada Y.-I., Enokido Y.,
RA   Marubuchi S., Harjes P., Arai N., Oyanagi K., Blandino G., Sudol M.,
RA   Rich T., Kanazawa I., Wanker E.E., Saitoe M., Okazawa H.;
RT   "Transcriptional repression induces a slowly progressive atypical neuronal
RT   death associated with changes of YAP isoforms and p73.";
RL   J. Cell Biol. 172:589-604(2006).
RN   [2]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-94 AND THR-95, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=16641100; DOI=10.1073/pnas.0600895103;
RA   Hoffert J.D., Pisitkun T., Wang G., Shen R.-F., Knepper M.A.;
RT   "Quantitative phosphoproteomics of vasopressin-sensitive renal cells:
RT   regulation of aquaporin-2 phosphorylation at two sites.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:7159-7164(2006).
RN   [3]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-46; SER-90; SER-94; THR-104
RP   AND SER-320, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Transcriptional regulator with dual roles as a coactivator
CC       and corepressor. Critical downstream regulatory target in the Hippo
CC       signaling pathway, crucial for organ size control and tumor suppression
CC       by restricting proliferation and promoting apoptosis (PubMed:16461361).
CC       The Hippo signaling pathway core involves a kinase cascade featuring
CC       STK3/MST2 and STK4/MST1, along with its regulatory partner SAV1, which
CC       phosphorylates and activates LATS1/2 in complex with their regulatory
CC       protein, MOB1. This activation leads to the phosphorylation and
CC       inactivation of the YAP1 oncoprotein and WWTR1/TAZ. Phosphorylation of
CC       YAP1 by LATS1/2 prevents its nuclear translocation, thereby regulating
CC       the expression of its target genes. The transcriptional regulation of
CC       gene expression requires TEAD transcription factors and modulates cell
CC       growth, anchorage-independent growth, and induction of epithelial-
CC       mesenchymal transition (EMT). Plays a key role in tissue tension and 3D
CC       tissue shape by regulating the cortical actomyosin network, acting via
CC       ARHGAP18, a Rho GTPase activating protein that suppresses F-actin
CC       polymerization. It also suppresses ciliogenesis by acting as a
CC       transcriptional corepressor of TEAD4 target genes AURKA and PLK1 (By
CC       similarity). In conjunction with WWTR1, regulates TGFB1-dependent SMAD2
CC       and SMAD3 nuclear accumulation (By similarity). Synergizes with WBP2 to
CC       enhance PGR activity (By similarity). {ECO:0000250|UniProtKB:P46937,
CC       ECO:0000250|UniProtKB:P46938, ECO:0000269|PubMed:16461361}.
CC   -!- FUNCTION: [Isoform 4]: Attenuates p73-mediated cell death signaling in
CC       transcriptional repression-induced atypical death (TRIAD) of neurons.
CC       {ECO:0000269|PubMed:16461361}.
CC   -!- FUNCTION: [Isoform 3]: Attenuates p73-mediated cell death signaling in
CC       transcriptional repression-induced atypical death (TRIAD) of neurons.
CC       {ECO:0000269|PubMed:16461361}.
CC   -!- FUNCTION: [Isoform 2]: Attenuates p73-mediated cell death signaling in
CC       transcriptional repression-induced atypical death (TRIAD) of neurons.
CC       {ECO:0000269|PubMed:16461361}.
CC   -!- SUBUNIT: Binds to the SH3 domain of the YES kinase. Binds to WBP1 and
CC       WBP2. Binds, in vitro, through the WW1 domain, to neural isoforms of
CC       ENAH that contain the PPSY motif (By similarity). The phosphorylated
CC       form interacts with YWHAB. Interacts (via WW domains) with LATS1 (via
CC       PPxY motif 2). Interacts with LATS2. Interacts (via WW domain 1) with
CC       ERBB4 (via PPxY motif 2). Interacts with TEAD1, TEAD2, TEAD3 and TEAD4.
CC       Interacts with TP73. Interacts with RUNX1. Interacts with HCK.
CC       Interacts (via WW domains) with PTPN14 (via PPxY motif 2); this
CC       interaction leads to the cytoplasmic sequestration of YAP1 and inhibits
CC       its transcriptional coactivator activity (By similarity). Interacts
CC       (when phosphorylated at Ser-112) with SMAD2, SMAD3 and WWTR1 (By
CC       similarity). Interacts with PRRG2 (via cytoplasmic domain) (By
CC       similarity). Interacts (via WW domains) with PRRG4 (via cytoplasmic
CC       domain) (By similarity). Interacts (phosphorylated) with CLDN18; the
CC       interaction sequesters YAP1 away from the nucleus and thereby restricts
CC       transcription of YAP1 target genes (By similarity). Interacts with
CC       SMAD1 (By similarity). Interacts with AMOT; the interaction facilitates
CC       translocation of YAP1 to the cytoplasm and tight junctions (By
CC       similarity). Interacts with AMOTL2, the interaction is required for
CC       ubiquitination of AMOTL2 and localization of YAP1 to tight junctions
CC       (By similarity). {ECO:0000250|UniProtKB:P46937,
CC       ECO:0000250|UniProtKB:P46938}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P46937}. Nucleus
CC       {ECO:0000250|UniProtKB:P46937}. Cell junction, tight junction
CC       {ECO:0000250|UniProtKB:A0A8C0NGY6}. Note=Both phosphorylation and cell
CC       density can regulate its subcellular localization (By similarity).
CC       Phosphorylation sequesters it in the cytoplasm by inhibiting its
CC       translocation into the nucleus (By similarity). At low density,
CC       predominantly nuclear and is translocated to the cytoplasm at high
CC       density. PTPN14 induces translocation from the nucleus to the cytoplasm
CC       (By similarity). In the nucleus, phosphorylation by PRP4K induces
CC       nuclear exclusion (By similarity). Localized mainly to the nucleus in
CC       the early stages of embryo development with expression becoming evident
CC       in the cytoplasm at the blastocyst and epiblast stages (By similarity).
CC       Localizes to the cytoplasm and tight junctions following interaction
CC       with AMOT (By similarity). Localizes to tight junctions following
CC       interaction with AMOTL2 (By similarity). Translocates to the nucleus in
CC       the presence of SNAIL1 (By similarity).
CC       {ECO:0000250|UniProtKB:A0A8C0NGY6, ECO:0000250|UniProtKB:P46937,
CC       ECO:0000250|UniProtKB:P46938}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC         Comment=Additional isoforms may exist.;
CC       Name=1;
CC         IsoId=Q2EJA0-1; Sequence=Displayed;
CC       Name=2; Synonyms=Neuron-specific YAPdeltaC insert25 isoform;
CC         IsoId=Q2EJA0-2; Sequence=VSP_039048, VSP_039051;
CC       Name=3; Synonyms=Neuron-specific YAPdeltaC insert61 isoform;
CC         IsoId=Q2EJA0-3; Sequence=VSP_039047, VSP_039052;
CC       Name=4; Synonyms=Neuron-specific YAPdeltaC insert13 isoform;
CC         IsoId=Q2EJA0-4; Sequence=VSP_039049, VSP_039050;
CC   -!- TISSUE SPECIFICITY: [Isoform 3]: Highly specific to cortical neurons.
CC       {ECO:0000269|PubMed:16461361}.
CC   -!- INDUCTION: Down-regulated by alpha-amanitin (AMA).
CC       {ECO:0000269|PubMed:16461361}.
CC   -!- DOMAIN: The first coiled-coil region mediates most of the interaction
CC       with TEAD transcription factors. {ECO:0000250|UniProtKB:P46937}.
CC   -!- PTM: Phosphorylated by LATS1 and LATS2; leading to cytoplasmic
CC       translocation and inactivation. Phosphorylated by ABL1; leading to YAP1
CC       stabilization, enhanced interaction with TP73 and recruitment onto
CC       proapoptotic genes; in response to DNA damage. Phosphorylation at Ser-
CC       366 and Ser-369 by CK1 is triggered by previous phosphorylation at Ser-
CC       363 by LATS proteins and leads to YAP1 ubiquitination by SCF(beta-TRCP)
CC       E3 ubiquitin ligase and subsequent degradation (By similarity).
CC       Phosphorylated at Thr-104, Thr-136, Ser-333 and Thr-378 by MAPK8/JNK1
CC       and MAPK9/JNK2, which is required for the regulation of apoptosis by
CC       YAP1 (By similarity). {ECO:0000250|UniProtKB:P46937}.
CC   -!- PTM: Lactylation by AARS1 promotes nuclear localization and
CC       stabilization of YAP1, leading to increased Hippo signaling pathway.
CC       Delactylated by SIRT1. {ECO:0000250|UniProtKB:P46937}.
CC   -!- PTM: Ubiquitinated by SCF(beta-TRCP) E3 ubiquitin ligase.
CC       {ECO:0000250|UniProtKB:P46937}.
CC   -!- SIMILARITY: Belongs to the YAP1 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; DQ186896; ABA33615.2; -; mRNA.
DR   EMBL; DQ186897; ABA33616.2; -; mRNA.
DR   EMBL; DQ186898; ABA33617.2; -; mRNA.
DR   EMBL; DQ376007; ABD32155.1; -; mRNA.
DR   RefSeq; NP_001029174.2; NM_001034002.2.
DR   RefSeq; XP_006242555.1; XM_006242493.3.
DR   AlphaFoldDB; Q2EJA0; -.
DR   SMR; Q2EJA0; -.
DR   STRING; 10116.ENSRNOP00000008074; -.
DR   GlyGen; Q2EJA0; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q2EJA0; -.
DR   PhosphoSitePlus; Q2EJA0; -.
DR   PaxDb; 10116-ENSRNOP00000034369; -.
DR   Ensembl; ENSRNOT00000008074.8; ENSRNOP00000008074.8; ENSRNOG00000005933.9. [Q2EJA0-4]
DR   Ensembl; ENSRNOT00000087278.2; ENSRNOP00000071631.2; ENSRNOG00000005933.9. [Q2EJA0-3]
DR   UCSC; RGD:1306035; rat. [Q2EJA0-1]
DR   AGR; RGD:1306035; -.
DR   RGD; 1306035; Yap1.
DR   VEuPathDB; HostDB:ENSRNOG00000005933; -.
DR   eggNOG; KOG0940; Eukaryota.
DR   GeneTree; ENSGT00510000046760; -.
DR   InParanoid; Q2EJA0; -.
DR   OrthoDB; 2593247at2759; -.
DR   Reactome; R-RNO-1251985; Nuclear signaling by ERBB4.
DR   Reactome; R-RNO-2028269; Signaling by Hippo.
DR   Reactome; R-RNO-2032785; YAP1- and WWTR1 (TAZ)-stimulated gene expression.
DR   Reactome; R-RNO-8939236; RUNX1 regulates transcription of genes involved in differentiation of HSCs.
DR   Reactome; R-RNO-8951671; RUNX3 regulates YAP1-mediated transcription.
DR   PRO; PR:Q2EJA0; -.
DR   Proteomes; UP000002494; Chromosome 8.
DR   Bgee; ENSRNOG00000005933; Expressed in esophagus and 18 other cell types or tissues.
DR   ExpressionAtlas; Q2EJA0; baseline and differential.
DR   GO; GO:0005911; C:cell-cell junction; ISS:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; ISO:RGD.
DR   GO; GO:0001674; C:female germ cell nucleus; ISO:RGD.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0140552; C:TEAD-YAP complex; ISO:RGD.
DR   GO; GO:0005667; C:transcription regulator complex; ISO:RGD.
DR   GO; GO:0003682; F:chromatin binding; ISO:RGD.
DR   GO; GO:0140297; F:DNA-binding transcription factor binding; ISO:RGD.
DR   GO; GO:0070064; F:proline-rich region binding; ISO:RGD.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:0000976; F:transcription cis-regulatory region binding; ISS:UniProtKB.
DR   GO; GO:0003713; F:transcription coactivator activity; ISS:UniProtKB.
DR   GO; GO:0003712; F:transcription coregulator activity; ISO:RGD.
DR   GO; GO:0003714; F:transcription corepressor activity; ISO:RGD.
DR   GO; GO:0001824; P:blastocyst development; ISO:RGD.
DR   GO; GO:0060449; P:bud elongation involved in lung branching; ISO:RGD.
DR   GO; GO:0060070; P:canonical Wnt signaling pathway; ISO:RGD.
DR   GO; GO:0061026; P:cardiac muscle tissue regeneration; ISO:RGD.
DR   GO; GO:0000902; P:cell morphogenesis; ISO:RGD.
DR   GO; GO:0008283; P:cell population proliferation; ISO:RGD.
DR   GO; GO:0071480; P:cellular response to gamma radiation; ISS:UniProtKB.
DR   GO; GO:0071300; P:cellular response to retinoic acid; ISO:RGD.
DR   GO; GO:0006974; P:DNA damage response; ISO:RGD.
DR   GO; GO:0003143; P:embryonic heart tube morphogenesis; ISO:RGD.
DR   GO; GO:1903703; P:enterocyte differentiation; ISO:RGD.
DR   GO; GO:0050673; P:epithelial cell proliferation; ISS:UniProtKB.
DR   GO; GO:0097191; P:extrinsic apoptotic signaling pathway; ISO:RGD.
DR   GO; GO:0002067; P:glandular epithelial cell differentiation; ISO:RGD.
DR   GO; GO:0003015; P:heart process; ISO:RGD.
DR   GO; GO:0035329; P:hippo signaling; ISO:RGD.
DR   GO; GO:0070102; P:interleukin-6-mediated signaling pathway; ISO:RGD.
DR   GO; GO:0060576; P:intestinal epithelial cell development; ISO:RGD.
DR   GO; GO:0060575; P:intestinal epithelial cell differentiation; ISO:RGD.
DR   GO; GO:0030216; P:keratinocyte differentiation; ISO:RGD.
DR   GO; GO:0048368; P:lateral mesoderm development; ISO:RGD.
DR   GO; GO:0060487; P:lung epithelial cell differentiation; ISO:RGD.
DR   GO; GO:1902018; P:negative regulation of cilium assembly; ISS:UniProtKB.
DR   GO; GO:1904036; P:negative regulation of epithelial cell apoptotic process; ISO:RGD.
DR   GO; GO:0030857; P:negative regulation of epithelial cell differentiation; ISO:RGD.
DR   GO; GO:2001237; P:negative regulation of extrinsic apoptotic signaling pathway; ISO:RGD.
DR   GO; GO:0045599; P:negative regulation of fat cell differentiation; ISO:RGD.
DR   GO; GO:0010629; P:negative regulation of gene expression; ISO:RGD.
DR   GO; GO:2000737; P:negative regulation of stem cell differentiation; ISO:RGD.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISS:UniProtKB.
DR   GO; GO:0030903; P:notochord development; ISO:RGD.
DR   GO; GO:0035265; P:organ growth; ISS:UniProtKB.
DR   GO; GO:0048339; P:paraxial mesoderm development; ISO:RGD.
DR   GO; GO:0090263; P:positive regulation of canonical Wnt signaling pathway; ISO:RGD.
DR   GO; GO:0060045; P:positive regulation of cardiac muscle cell proliferation; ISO:RGD.
DR   GO; GO:0030307; P:positive regulation of cell growth; ISO:RGD.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; ISO:RGD.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:0050679; P:positive regulation of epithelial cell proliferation; ISO:RGD.
DR   GO; GO:0010628; P:positive regulation of gene expression; ISO:RGD.
DR   GO; GO:0045747; P:positive regulation of Notch signaling pathway; ISO:RGD.
DR   GO; GO:0046622; P:positive regulation of organ growth; ISO:RGD.
DR   GO; GO:0045669; P:positive regulation of osteoblast differentiation; ISO:RGD.
DR   GO; GO:1900182; P:positive regulation of protein localization to nucleus; ISS:UniProtKB.
DR   GO; GO:1902459; P:positive regulation of stem cell population maintenance; ISO:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0065003; P:protein-containing complex assembly; ISO:RGD.
DR   GO; GO:0060828; P:regulation of canonical Wnt signaling pathway; ISO:RGD.
DR   GO; GO:0042127; P:regulation of cell population proliferation; ISO:RGD.
DR   GO; GO:0010468; P:regulation of gene expression; ISO:RGD.
DR   GO; GO:0010837; P:regulation of keratinocyte proliferation; ISO:RGD.
DR   GO; GO:0072307; P:regulation of metanephric nephron tubule epithelial cell differentiation; ISO:RGD.
DR   GO; GO:0050767; P:regulation of neurogenesis; ISO:RGD.
DR   GO; GO:0072091; P:regulation of stem cell proliferation; ISO:RGD.
DR   GO; GO:0032570; P:response to progesterone; ISO:RGD.
DR   GO; GO:0042770; P:signal transduction in response to DNA damage; ISS:UniProtKB.
DR   GO; GO:0035019; P:somatic stem cell population maintenance; ISO:RGD.
DR   GO; GO:0001894; P:tissue homeostasis; ISO:RGD.
DR   GO; GO:0001829; P:trophectodermal cell differentiation; ISO:RGD.
DR   GO; GO:0001570; P:vasculogenesis; ISO:RGD.
DR   GO; GO:0042060; P:wound healing; ISO:RGD.
DR   CDD; cd00201; WW; 2.
DR   Gene3D; 2.20.70.10; -; 2.
DR   Gene3D; 6.20.430.10; -; 1.
DR   InterPro; IPR053819; TEADIR3_omega_loop.
DR   InterPro; IPR001202; WW_dom.
DR   InterPro; IPR036020; WW_dom_sf.
DR   InterPro; IPR051583; YAP1.
DR   PANTHER; PTHR17616:SF9; TRANSCRIPTIONAL COACTIVATOR YAP1; 1.
DR   PANTHER; PTHR17616; YES-ASSOCIATED PROTEIN YAP1 FAMILY MEMBER; 1.
DR   Pfam; PF15238; TEADIR3; 1.
DR   Pfam; PF00397; WW; 2.
DR   SMART; SM00456; WW; 2.
DR   SUPFAM; SSF51045; WW domain; 2.
DR   PROSITE; PS01159; WW_DOMAIN_1; 2.
DR   PROSITE; PS50020; WW_DOMAIN_2; 2.
PE   1: Evidence at protein level;
KW   Activator; Alternative splicing; Cell junction; Coiled coil; Cytoplasm;
KW   Nucleus; Phosphoprotein; Proto-oncogene; Reference proteome; Repeat;
KW   Repressor; Tight junction; Transcription; Transcription regulation;
KW   Ubl conjugation.
FT   CHAIN           1..469
FT                   /note="Transcriptional coactivator YAP1"
FT                   /id="PRO_0000393772"
FT   DOMAIN          153..186
FT                   /note="WW 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00224"
FT   DOMAIN          212..245
FT                   /note="WW 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00224"
FT   REGION          1..47
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          76..99
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          258..290
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          273..469
FT                   /note="Transactivation domain"
FT   REGION          345..405
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          71..85
FT                   /evidence="ECO:0000250"
FT   COILED          280..325
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        1..34
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        275..290
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        345..379
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        389..405
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         46
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         48
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P46937"
FT   MOD_RES         75
FT                   /note="N6-lactoyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P46937"
FT   MOD_RES         90
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         94
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:16641100,
FT                   ECO:0007744|PubMed:22673903"
FT   MOD_RES         95
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:16641100"
FT   MOD_RES         104
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         112
FT                   /note="Phosphoserine; by LATS1 and LATS2"
FT                   /evidence="ECO:0000250|UniProtKB:P46937"
FT   MOD_RES         113
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P46937"
FT   MOD_RES         116
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P46937"
FT   MOD_RES         136
FT                   /note="Phosphothreonine; by MAPK8 and MAPK9"
FT                   /evidence="ECO:0000250|UniProtKB:P46937"
FT   MOD_RES         146
FT                   /note="Phosphoserine; by LATS1 and LATS2"
FT                   /evidence="ECO:0000250|UniProtKB:P46937"
FT   MOD_RES         271
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P46937"
FT   MOD_RES         320
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         333
FT                   /note="Phosphoserine; by MAPK8 and MAPK9"
FT                   /evidence="ECO:0000250|UniProtKB:P46937"
FT   MOD_RES         347
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P46937"
FT   MOD_RES         348
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P46937"
FT   MOD_RES         354
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P46937"
FT   MOD_RES         363
FT                   /note="Phosphoserine; by LATS1 and LATS2"
FT                   /evidence="ECO:0000250|UniProtKB:P46937"
FT   MOD_RES         366
FT                   /note="Phosphoserine; by CK1"
FT                   /evidence="ECO:0000250|UniProtKB:P46937"
FT   MOD_RES         369
FT                   /note="Phosphoserine; by CK1"
FT                   /evidence="ECO:0000250|UniProtKB:P46937"
FT   MOD_RES         373
FT                   /note="Phosphotyrosine; by ABL1"
FT                   /evidence="ECO:0000250|UniProtKB:P46937"
FT   MOD_RES         378
FT                   /note="Phosphothreonine; by MAPK8 and MAPK9"
FT                   /evidence="ECO:0000250|UniProtKB:P46937"
FT   VAR_SEQ         311..366
FT                   /note="ELALRSQLPSLEQDGGTQNAVSSPGMTQELRTMTTNSSDPFLNSGTYHSRDE
FT                   STDS -> AIRNINPSTANAPKCQTVRAGISSPQPVALTGAGWRDSECSVFSRDDSGIE
FT                   DNDNQ (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:16461361"
FT                   /id="VSP_039047"
FT   VAR_SEQ         311..354
FT                   /note="ELALRSQLPSLEQDGGTQNAVSSPGMTQELRTMTTNSSDPFLNS -> VRPQ
FT                   TVRAGISSPQPVALTGAGWRDSECSVFSRDDSGIEDNDNQ (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:16461361"
FT                   /id="VSP_039048"
FT   VAR_SEQ         311..350
FT                   /note="ELALRSQLPSLEQDGGTQNAVSSPGMTQELRTMTTNSSDP -> TVRAGISS
FT                   PQPVALTGAGWRDSECSVFSRDDSGIEDNDNQ (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:16461361"
FT                   /id="VSP_039049"
FT   VAR_SEQ         351..469
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:16461361"
FT                   /id="VSP_039050"
FT   VAR_SEQ         355..469
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:16461361"
FT                   /id="VSP_039051"
FT   VAR_SEQ         367..469
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:16461361"
FT                   /id="VSP_039052"
SQ   SEQUENCE   469 AA;  50501 MW;  98252AF782DE1907 CRC64;
     MEPAQQPPPQ PAPQGPAPPS VSPAGTPAAP PAPPAGHQVV HVRGDSETDL EALFNAVMNP
     KTANVPQTVP MRLRKLPDSF FKPPEPKSHS RQASTDAGTA GALTPQHVRA HSSPASLQLG
     AGTLTASGVV SGPAATPAAQ HLRQSSFEIP DDVPLPAGWE MAKTSSGQRY FLNHNDQTTT
     WQDPRKAMLS QLNVPTSASP AVPQTLMNSA SGPLPDGWEQ AMTQDGEVYY INHKNKTTSW
     LDPRLDPRFA MNQRITQSAP VKQPPPLAPQ SPQGGVLGGG SSNQQQQIQL QQLQMEKERL
     RLKQQELFRQ ELALRSQLPS LEQDGGTQNA VSSPGMTQEL RTMTTNSSDP FLNSGTYHSR
     DESTDSGLSM SSYSIPRTPD DFLNSVDEMD TGDTISQSTL PSQQSRFPDY LEALPGTNVD
     LGTLEGDAMN IEGEELMPSL QEALSSEILD VESVLAATKL DKESFLTWL
//
